Clinical Trial Update: Percutaneous Coronary Intervention Followed by Antiplatelet Monotherapy in the Setting of Acute Coronary Syndromes [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating percutaneous coronary intervention followed by antiplatelet monotherapy in acute coronary syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Snippet

Sponsor: Hospital Israelita Albert Einstein | Conditions: Acute Coronary Syndrome | Phase 3 | Status: COMPLETED